Advertisement

Wal-Mart Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts | Equate Naproxen Sodium

00:03 EDT 21st May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

Pain reliever/fever reducer

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

ask a health professional before use. It is especially important not to use naproxen sodium during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

adults and children 12 years and older: take 1 capsule every 8 to 12 hours while symptoms last for the first dose you may take 2 capsules within the first hour do not exceed 2 capsules in any 8- to 12- hour period do not exceed 3 capsules in a 24 hour period
children under 12 years: ask a doctor

FD&C Blue #1, gelatin, glycerin, lactic acid, mannitol, pharmaceutical ink, polyethylene glycol, povidone, propylene glycol, purified water, sorbitan, sorbitol

1-888-287-1915

SEE NEW WARNINGS INFORMATION

Naproxen Sodium Capsules, 220 mg (NSAID)

Pain Reliever/Fever Reducer

Actual Size

220 mg

**Liquid Filled Capsules

IMAGE 414da4d8-919a-4441-8ac4-95c4870904c1-01.jpgIMAGE 414da4d8-919a-4441-8ac4-95c4870904c1-02.jpg

Manufacturer

Wal-Mart Stores Inc

Active Ingredients

Source

Clinical Trials [ 925 Associated Clinical Trials listed on BioPortfolio]

Naproxen Sodium ER Pharmacokinetic Study

To determine the pharmacokinetic profile of the investigational product following dosing under fed conditions.

Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions

The purpose of this study is to assess the bioequivalence of Naproxen sodium 220 mg + Pseudoephedrine Hydrochloride 120 mg Extended Release tablets of with Aleve Cold and Sinus in healthy...

Fast & Fed Pharmacokinetic (PK) Study

The purpose of this study is to provide information on how well an extended release formulation (a medication that is released and absorbed over a longer period of time than a regular rele...

Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

To compare the pharmacokinetic profile of the proposed extended- release tablet of naproxen sodium 660 mg relative to two tablets of Naprelan 500 mg following single dose administration fo...

Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

The purpose of this study is to assess the bioequivalence of Naproxen sodium 220 mg + Pseudoephedrine Hydrochloride 120 mg Extended Release tablets of with Aleve Cold and Sinus in healthy...

PubMed Articles [ 2590 Associated PubMed Articles listed on BioPortfolio]

Reduced Ulcerogenic Potential and Antiarthritic Effect of Chitosan-Naproxen Sodium Complexes.

The purpose of this research was to address the utility of naproxen sodium-chitosan spray-dried complexes for antiulcer and antiarthritic activities. The cold stress technique was used to examine the...

Exploring the Solid-Form Landscape of Pharmaceutical Hydrates: Transformation Pathways of the Sodium Naproxen Anhydrate-Hydrate System.

PURPOSE: To understand the transformation pathways amongst anhydrate/hydrate solid forms of sodium naproxen and to highlight the importance of a polymorphic dihydrate within this context. METHODS: Mul...

Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.

Evaluation of: Cady RK, Diamond ML, Diamond MP et al. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. Headache 51(5...

Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: Recommendations to minimize the functional consequences.

To investigate whether low-dose naproxen sodium (220 mg twice a day) interferes with aspirin's antiplatelet effect in healthy subjects.

Naproxen Interferes with the Assembly of Aβ Oligomers Implicated in Alzheimer's Disease.

Experimental and epidemiological studies have shown that the nonsteroidal antiinflammatory drug naproxen may be useful in the treatment of Alzheimer's disease. To investigate the interactions of napro...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement